We hope this will lead to a cessation of the constant rocket fire on Israeli towns and citiesIsraeli-Hamas cease-fire to begin Thursday Jun 18, 2008
The enzyme we have discovered, a protein kinasea, is essential for the development of malaria parasite gametesNew technique for malaria control reported Jun 04, 2008
Syria continues to be more interested in providing safe haven to the 11 terrorist groups it is harboring in Damascus and fomenting terror against Israel wherever it canSyria says it's ready for peace talks Apr 12, 2007
This terror attack is precisely what the new Palestinian government refuses to condemn, thus rejecting the conditions placed upon it by the international communityHamas admits shooting Israeli worker Mar 19, 2007
One shouldn't get the mistaken impression that the Palestinians have abandoned their campaign of terror against IsraelIsraeli terror deaths down 50 percent Jan 08, 2004
David Baker (born October 6, 1962 in Seattle, Washington) is an American biochemist and computational biologist who studies methods to predict the three-dimensional structures of proteins. He is a Professor of Biochemistry at the University of Washington, where he is the principal investigator of the 30+ member Baker laboratory. He is a Howard Hughes Medical Institute investigator, and as of April 2006, also a member of the United States National Academy of Sciences.
The Baker laboratory developed the Rosetta algorithm for ab initio protein structure prediction, which has been extended to a distributed computing project called Rosetta@Home. The project aims to produce structural models for protein complexes as well as individual polypeptide chains. The Baker group participates regularly and is recognized for expertise in the CASP structure prediction experiment using ab initio methods, including both manually assisted and automated variants of the Rosetta protocol.
Members of the Baker group are also active in the field of protein design; they are recognized as the first group to have designed a protein, known as Top7, with an entirely novel fold.